DSwiss Inc. 2025 Annual Report: Key Investor Insights and Potential Share Price Movers

Overview

DSwiss Inc., a Nevada corporation headquartered in Kuala Lumpur, Malaysia, has released its annual report for the fiscal year ended December 31, 2025. The report offers a comprehensive insight into the company’s operational performance, strategy, risk factors, corporate structure, and future plans. The following analysis presents the most salient information for investors and highlights disclosures that may be materially significant for the company’s share value.

Key Points from the Annual Report

• Corporate Structure:
  • DSwiss Inc. has several wholly-owned subsidiaries, including DSwiss Holding Limited (Seychelles), DSwiss Sdn Bhd (Malaysia), and DSwiss Biotech Sdn Bhd (Malaysia).
  • Principal activities: Investment holding, supply of healthcare products, and R&D in biotechnology.
  • All subsidiaries are 100% owned, giving DSwiss full control over their operations.
• Shares Outstanding:
  • As of December 31, 2025, DSwiss had 206,904,585 shares of common stock with a par value of \$0.0001 issued and outstanding.
  • There are 430 beneficial owners of the company’s common stock.
• Penny Stock Status & Trading:
  • DSwiss common stock may be classified as “penny stock” by the SEC, which could limit liquidity and make it more difficult for broker-dealers to recommend the stock to investors.
  • Recent bid prices in 2025: Q3 high \$0.10/low \$0.02; Q4 high \$0.04/low \$0.03.
  • The company has no equity compensation plan in place and has not repurchased any shares in 2025.
• Financial Performance:
  • Gross margin decreased from 20.02% in 2024 to 19.33% in 2025, a net drop of 0.69%.
  • Cost of sales increased by 4.46% (\$26,925 rise to \$603,720).
  • Operating expenses fell slightly by 2.99% (\$36 decrease to \$1,167).
  • Other income rose significantly from \$13,300 (2024) to \$40,175 (2025), primarily from gains on equipment disposal, interest income, and exchange gains.
  • The company’s revenues from ongoing operations were sufficient to fund business activities and planned growth, but management signals the possibility of seeking additional capital in the future, including equity or debt financing, if needed.
• Future Growth Strategy:
  • DSwiss is focused on expanding its presence in Southeast Asia through recruitment of distributors and aggressive social media marketing (Facebook & Instagram).
  • Plans to invest substantially in marketing and advertising in 2026, aiming for a 100% increase in social media engagement by year-end.
  • Growth to be fueled by partnerships with biotech/life science and retail technology providers, and offering comprehensive biotechnology, nutraceutical, and skincare solutions (including private label manufacturing).
• Cybersecurity & Risk Management:
  • DSwiss has not experienced any material cybersecurity incidents impacting performance or finances in 2025.
  • Ongoing board-level oversight and risk management processes are in place to monitor and mitigate emerging threats.
• Legal Proceedings:
  • No significant legal proceedings disclosed; litigation risks are described as inherent to normal business operations.
• Dividend Policy:
  • There are no current plans to pay dividends. All earnings are intended to be retained to support business growth and operations.
• Shareholder Sensitive Disclosures:
  • The company’s classification as a penny stock and related liquidity challenges could impact investor ability to trade shares.
  • Management’s openness to future capital raising (debt or equity) could dilute existing shareholders if new shares are issued.
  • Gross margin is decreasing, but other income is rising, offsetting some pressure on net results.
  • No equity compensation plan or share buyback program is currently in place, which may be noteworthy for those monitoring dilution or capital return policies.
• Competition & Market Outlook:
  • The beauty and healthcare sectors are highly competitive and rapidly evolving. DSwiss is leveraging its team’s expertise and digital marketing to reinforce market position and brand awareness.

Potential Price-Sensitive Information

• Liquidity and Shareholder Value: Penny stock status and limited trading liquidity may restrict share price appreciation and make selling shares difficult for investors.
• Capital Raising: Potential for future equity or debt financing could lead to dilution or increased financial leverage.
• Gross Margin Pressure: The declining gross margin, if continued, may affect profitability and investor sentiment.
• Significant Increase in Other Income: The notable jump in other income (from \$13,300 to \$40,175) could reflect one-off gains; investors should assess the sustainability of such income streams.
• Growth Investments: Planned substantial marketing and advertising outlays could impact short-term earnings but may drive long-term growth if successful.
• No Dividend or Equity Compensation: No immediate shareholder returns via buybacks or dividends; may be a consideration for income-focused investors.

Summary

DSwiss Inc. is executing a growth-focused strategy in the health and beauty sector, expanding its Southeast Asian footprint through digital marketing and strategic partnerships. While operational revenues are funding current activities, management is open to future capital raises. Investors should note the stock’s penny status, declining gross margins, and planned increases in marketing spend. No dividends or share repurchases are planned, and there is no equity compensation scheme. The company remains vigilant on cybersecurity and legal risks, with no material incidents reported. These factors, especially future financing and market expansion, could materially influence DSwiss’s share price and investor returns.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full DSwiss Inc. 10-K report and consult with a qualified financial advisor before making investment decisions. The information provided is based on the company’s 2025 annual report and is subject to change without notice.

View DSwiss Inc Historical chart here